Clinical weight loss is driven by the active ingredient, semaglutide
Most sauces and condiments have added sugar
Unlike native GLP-1, which has a half-life of only 1-2 minutes due to rapid enzymatic cleavage, the unique lipidization of the Semaglutide Peptide allows it to strongly bind to serum albumin, facilitating a substantially prolonged half-life for extended observational studies
It signals the pancreas to release insulin when blood sugar rises, reduces liver glucose production by lowering glucagon, and slows gastric emptying to prolong the feeling of fullness
Because of the unknown potential for serious adverse reactions in the breastfed infant due to the possible accumulation of SNAC, and because there are alternative semaglutide products that do not contain SNAC that can be used during lactation, advise patients that breastfeeding is not recommended during treatment with RYBELSUS or OZEMPIC tablets